| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.03 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.092 | 0.03 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.099 | 0.03 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | 0.37 | 0.03 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.073 | 0.03 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.04 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.04 |